(Q38829170)

6 September 2017

title

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma (English)

1 reference

6 September 2017

Xiaoguang Li

1

1 reference

6 September 2017

Wenbo Yao

2

1 reference

6 September 2017

Ya Yuan

3

1 reference

6 September 2017

Peizhan Chen

4

1 reference

6 September 2017

Bin Li

5

1 reference

6 September 2017

Jingquan Li

6

1 reference

6 September 2017

Ruiai Chu

7

1 reference

6 September 2017

Haiyun Song

8

1 reference

6 September 2017

Dong Xie

9

1 reference

6 September 2017

Xiaoqing Jiang

10

1 reference

6 September 2017

Hui Wang

11

1 reference

6 September 2017

language of work or name

English

0 references

publication date

9 October 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

66

1 reference

6 September 2017

issue

1

1 reference

6 September 2017

page(s)

157-167

1 reference

6 September 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Role of tumor-associated macrophages in the progression of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Development of monocytes, macrophages, and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Therapeutic siRNA silencing in inflammatory monocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Monocyte recruitment during infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Functional role of chemokines in liver disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Chemokine receptor antagonists: overcoming developmental hurdles

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Differential macrophage programming in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Tumor-associated macrophages: from mechanisms to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

21 January 2018

Immunotherapy of HCC.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

The future of immune checkpoint therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Anti-tumour strategies aiming to target tumour-associated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Hepatocellular carcinoma: A global view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310514

10.1136/GUTJNL-2015-310514

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference